Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedJul 03, 2026
DataAggregated Company Financials
Companies72
  • 7D9.3%
  • 3M45.9%
  • 1Y72.1%
  • YTD54.2%

Over the last 7 days, the Biotech industry has risen 10%, driven by gains from PharmaEssentia of 17%. This takes the industry's 12 month performance to a gain of 69%. As for the next few years, earnings are expected to grow by 50% per annum.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Jul 2026NT$959.9bNT$36.8b-NT$8,983,989,000.0029.6x-106.8x26.1x
Sun, 31 May 2026NT$723.0bNT$36.8b-NT$8,955,294,000.0028.6x-80.7x19.7x
Tue, 28 Apr 2026NT$627.5bNT$34.5b-NT$10,365,261,000.0029.6x-60.5x18.2x
Thu, 26 Mar 2026NT$638.6bNT$34.3b-NT$10,878,927,500.0029.2x-58.7x18.6x
Sat, 21 Feb 2026NT$683.1bNT$33.4b-NT$8,958,095,000.0029.6x-76.3x20.4x
Mon, 19 Jan 2026NT$620.6bNT$33.4b-NT$7,105,005,000.0030x-87.3x18.6x
Wed, 17 Dec 2025NT$574.4bNT$33.4b-NT$6,850,221,000.0029.8x-83.8x17.2x
Fri, 14 Nov 2025NT$519.0bNT$33.3b-NT$7,234,614,000.0034.2x-71.7x15.6x
Sun, 12 Oct 2025NT$558.2bNT$32.2b-NT$8,364,979,000.0036.7x-66.7x17.3x
Tue, 09 Sep 2025NT$542.3bNT$32.2b-NT$8,665,529,000.0034.5x-62.6x16.8x
Thu, 07 Aug 2025NT$519.6bNT$30.7b-NT$7,745,785,000.0036.4x-67.1x16.9x
Sat, 05 Jul 2025NT$506.8bNT$30.2b-NT$6,425,159,000.0037.3x-78.9x16.8x
Mon, 02 Jun 2025NT$494.3bNT$30.0b-NT$6,515,799,000.0031.4x-75.9x16.5x
Wed, 30 Apr 2025NT$495.2bNT$28.6b-NT$7,430,422,000.0033.6x-66.6x17.3x
Fri, 28 Mar 2025NT$535.4bNT$28.1b-NT$7,681,273,000.0032x-69.7x19x
Sun, 23 Feb 2025NT$565.0bNT$24.8b-NT$10,951,391,000.0038.4x-51.6x22.8x
Tue, 21 Jan 2025NT$544.1bNT$24.8b-NT$10,902,841,000.0033.9x-49.9x21.9x
Thu, 19 Dec 2024NT$499.7bNT$23.9b-NT$11,218,669,000.0033x-44.5x20.9x
Sat, 16 Nov 2024NT$514.1bNT$23.5b-NT$10,629,142,000.0036.6x-48.4x21.9x
Mon, 14 Oct 2024NT$531.8bNT$23.5b-NT$10,829,095,000.0035.4x-49.1x22.6x
Wed, 11 Sep 2024NT$560.5bNT$23.5b-NT$10,829,095,000.0033.4x-51.8x23.9x
Fri, 09 Aug 2024NT$539.7bNT$22.1b-NT$11,344,850,000.0033.4x-47.6x24.5x
Sun, 07 Jul 2024NT$555.9bNT$21.9b-NT$11,110,643,000.0043.4x-50x25.3x
Tue, 04 Jun 2024NT$497.2bNT$21.9b-NT$11,110,643,000.0042.1x-44.8x22.7x
Thu, 02 May 2024NT$444.2bNT$21.1b-NT$12,460,151,000.0049x-35.7x21x
Sat, 30 Mar 2024NT$436.5bNT$21.0b-NT$10,101,868,000.0051.9x-43.2x20.8x
Mon, 26 Feb 2024NT$446.3bNT$19.9b-NT$9,857,794,000.0040.1x-45.3x22.4x
Wed, 24 Jan 2024NT$432.7bNT$19.9b-NT$9,830,596,000.0039.9x-44x21.7x
Fri, 22 Dec 2023NT$468.8bNT$19.9b-NT$9,737,975,000.0043x-48.1x23.6x
Sun, 19 Nov 2023NT$475.9bNT$19.4b-NT$10,043,298,000.0043.7x-47.4x24.5x
Tue, 17 Oct 2023NT$461.8bNT$18.3b-NT$10,774,226,000.0045x-42.9x25.2x
Thu, 14 Sep 2023NT$484.5bNT$18.3b-NT$10,776,417,000.0042.3x-45x26.5x
Sat, 12 Aug 2023NT$468.7bNT$18.9b-NT$10,012,564,000.0043.8x-46.8x24.7x
Mon, 10 Jul 2023NT$482.0bNT$18.7b-NT$10,725,166,000.0044.5x-44.9x25.8x
Price to Earnings Ratio

-44.9x


Total Market Cap: NT$482.0bTotal Earnings: -NT$10,725,166,000.00Total Revenue: NT$18.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -58.1x202420252026
Current Industry PE
  • Investors are optimistic on the Taiwanese Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 21.0x is lower than the industry's current PS ratio of 25.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 25% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market0.94%
Healthcare4.61%
Biotech9.26%
Biotech9.26%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$1.40k20.8%
+NT$89.2b		186.2%PE87.4x
6696 Lin BioScienceNT$470.0019.0%
+NT$6.2b		236.9%PB3.6x
6617 Gongwin Biopharm HoldingsNT$92.6044.5%
+NT$3.5b		6.7%PS293.2x
6949 Pell Bio-Med TechnologyNT$897.004.1%
+NT$2.3b		469.5%PS2248.5x
4169 TCM Biotech InternationalNT$222.0015.6%
+NT$1.8b		281.4%PS18.6x

Latest News

6446
NT$1,395.00
PharmaEssentia
7D
20.8%
1Y
186.2%
7902
NT$39.45
Uwell Biopharma
7D
27.3%
1Y
n/a
6955
NT$120.50
Bonraybio
7D
-2.8%
1Y
-27.1%
6949
NT$897.00
Pell Bio-Med Technology
7D
4.1%
1Y
469.5%
7827
NT$163.00
HanchorBio
7D
-6.6%
1Y
150.8%
6810
NT$21.00
Bio Preventive Medicine
7D
-12.7%
1Y
-30.0%
6748
NT$151.50
ACRO Biomedical
7D
-10.4%
1Y
281.1%
1780
NT$24.60
Allied Biotech
7D
-4.5%
1Y
27.5%
6541
NT$41.10
Tanvex BioPharma
7D
6.6%
1Y
-23.7%
6550
NT$13.60
Polaris Group
7D
8.8%
1Y
-64.9%
6617
NT$92.60
Gongwin Biopharm Holdings
7D
44.5%
1Y
6.7%
7784
NT$10.20
Anbogen Therapeutics
7D
-8.9%
1Y
n/a
4169
NT$222.00
TCM Biotech International
7D
15.6%
1Y
281.4%
7808
NT$35.00
BIONET Therapeutics
7D
-4.8%
1Y
-18.3%
7729
NT$74.20
Steminent Biotherapeutics
7D
-4.9%
1Y
255.9%
6696
NT$470.00
Lin BioScience
7D
19.0%
1Y
236.9%